Enterovirus Infections  >>  EDP-239  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EDP-239 / Enanta Pharma
NCT01856426: Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects

Completed
1
28
US, Europe
EDP239, Placebo
Enanta Pharmaceuticals, Inc
Hepatitis C
11/14
10/15

Download Options